NCT04302688CompletedNot Applicable
Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram
Renmin Hospital of Wuhan University1 site in 1 country669 target enrollmentStarted: December 10, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 669
- Locations
- 1
- Primary Endpoint
- survival status
Study Overview
Brief Summary
The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.
Detailed Description
- First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group.
- Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility.
- Compared with SEPSIS and CURB-65 grading system with the grading system we established.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.
Exclusion Criteria
- •Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
- •Suspected patient review refers to the negative nucleic acid test.
Outcomes
Primary Outcomes
survival status
Time Frame: 10 December 2019 to 10 February 2020
survival status as of February 24, 2020
Secondary Outcomes
No secondary outcomes reported
Investigators
Gong Qiong
Professor
Renmin Hospital of Wuhan University
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension StudyCovid19Corona Virus InfectionMobility LimitationFrailtyNCT04602260McMaster University211
Unknown
Phase 3
Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 VirusCOVID - 19NCT04355052Sheba Medical Center250
Unknown
Not Applicable
Geriatric Population COVID-19 Observational Study (GEROCOVIDobs)COVID-19NCT04379440Raffaele Antonelli Incalzi1,500
Completed
Not Applicable
Evaluation of the care situation of patients with lymphedema during the Covid-19 pandemic.I89.0I97.2I97.80I82.0Lymphoedema, not elsewhere classifiedPostmastectomy lymphoedema syndromeBudd-Chiari syndromeDRKS00026728Charite Universitätsmedizin Berlin100
Unknown
Not Applicable
Solid Organ Transplant Recipients With SARS-CoV-2 French RegistrySARS-CoV-2NCT04360707University Hospital, Strasbourg, France300